FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, namely a method for individual's addictive behaviour correction. The method for individual's addictive behaviour correction involving the simultaneous introduction into the individual's body a combination of organic preparations: Hirnstamm D5, Placenta D5, Hypophysis D5, Thymus D5, according to the specific schedule in a combination with the course of psychotherapy.
EFFECT: developing the method for individual's addictive behaviour correction.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING AND REHABILITATION IN PATIENTS WITH GAMBLING GAME ADDICTION | 2004 |
|
RU2277899C2 |
| METHOD TO CORRECT ADDITIVE BEHAVIOR | 1997 |
|
RU2112559C1 |
| METHOD OF HUMAN AVITAL ACTIVITY TREATMENT | 2005 |
|
RU2329781C2 |
| METHOD OF PREVENTION OF STUDENTS' ADDICTIVE BEHAVIOUR | 2007 |
|
RU2354415C1 |
| METHOD OF TOBACCO DEPENDENCY TREATMENT AND ANTITOBACCO COMBINATION PREPARATION | 1998 |
|
RU2132203C1 |
| METHOD FOR EVALUATING PREDISPOSITION TO PRIMARY PATHOLOGICAL ATTRACTION TO PSYCHOACTIVE DRUGS IN TEENAGERS | 2003 |
|
RU2269937C2 |
| METHOD OF TREATING ALCOHOLISM AND/OR DRUG ADDICTION | 2008 |
|
RU2389515C1 |
| METHOD FOR PREDICTING THE INDIVIDUAL RISK OF DEVELOPMENT OF DISORDERS OF ADDITIVE CHARACTER | 2016 |
|
RU2621171C1 |
| METHOD OF TREATING PATIENTS WITH BORDERLINE NEUROPSYCHIC PATHOLOGY | 2019 |
|
RU2691512C1 |
| METHOD FOR TREATING NARCOMANIA | 2001 |
|
RU2197183C1 |
